DaVita Inc. Schedules 1st Quarter 2023 Investor Conference Call
DaVita Inc. (NYSE: DVA) has scheduled its quarterly conference call to discuss first-quarter results on May 8, 2023, at 5:00 p.m. Eastern Time. The results will be released after the market closes on the same day. The call will be available via webcast on the DaVita investor relations webpage. Investors can join by dialing 877-918-6630 (or 517-308-9042 internationally) and using the password 'Earnings'. For those unable to attend, a replay will be accessible on DaVita's website without a telephone replay option. As of December 31, 2022, DaVita served 200,000 patients across 2,724 outpatient dialysis centers in the U.S. and operated 350 centers in 11 other countries, focusing on improving care delivery and clinical outcomes for kidney health.
- Scheduled quarterly conference call for Q1 results on May 8, 2023.
- Accessibility for investors via both telephone and webcast.
- None.
DENVER, April 18, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 8, 2023, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:
Monday, May 8, 2023
Starting at 5:00 p.m. EDT
Webcast can be accessed using this link
Dial in number: 877-918-6630
International dial in: 517-308-9042
When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at investors.davita.com. There will be no telephone replay.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2022, DaVita served 200,000 patients at 2,724 outpatient dialysis centers in the United States. The company also operated 350 outpatient dialysis centers in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Contact Information
Investors:
IR@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-inc-schedules-1st-quarter-2023-investor-conference-call-301800709.html
SOURCE DaVita
FAQ
When will DaVita's Q1 2023 conference call be held?
How can I access DaVita's Q1 2023 results?
Is there a way to listen to DaVita's quarterly earnings call?